Case Studies
Stem Cell Therapy
Cancer Case Studies
GcMAF and Gall bladder Cancer
Patient Background: A 60-year-old female patient was diagnosed with stage III gallbladder cancer. She had a history of chronic gallbladder inflammation and presented to me Dr Celma with symptoms of jaundice, abdominal pain, and weight loss. Standard treatments, including surgery and chemotherapy, were considered, but the patient opted to explore alternative therapies.
Treatment Plan: The patient was introduced to GcMAF therapy as part of a clinical trial conducted by our team of 50 doctors. GcMAF was introduced. Gcmaf is known for its potential to activate macrophages and enhance the immune response, which was administered at 2500ng daily sub c (1ml daily taken from a 7500ng vial), for six months. The treatment aimed to boost the patient's immune system to target and destroy cancer cells.
Observations: Immune Response: Within the first two months, blood tests indicated a significant increase in macrophage activity and a reduction in nagalase levels, an enzyme produced by cancer cells to evade the immune system.
Tumour Reduction: Imaging studies after three months showed a reduction in tumour size by 30%. The patient reported decreased pain and improved appetite.
Quality of Life: The patient experienced an overall improvement in quality of life, with increased energy levels and reduced symptoms of jaundice.
Long-term Outcomes: After six months of GcMAF therapy, the tumour had shrunk by 80%, and there was no evidence of metastasis. The patient continued to receive maintenance doses of GcMAF for 10 months until remission status was achieved. and remained in stable condition with regular monitoring. The patient received regular monitoring for 5 years and is now in long-term remission.
Conclusion: This case study suggests that GcMAF therapy enhances the immune response against gallbladder cancer, leading to tumour reduction and improved quality of life. However, it is important to note that there have been diet and lifestyle changes, GcMAF formed only part of a more extensive protocol set by me Dr Celma and my team of 50 doctors.
This post should not be taken as medical advice. Always consult with healthcare professionals for treatment options.
#drfermincelma #gallbladdercancer #GcMAF #gcmafcancer #cancersurvivor
Autism, ADHD Case Studies
Gracie was one of 25 children who took part in the first-of-its-kind study at Duke University in Durham, North Carolina. The goal: to see whether a transfusion of their own umbilical cord blood containing rare stem cells could help treat their autism.
The results were impressive: More than two-thirds of the children showed reported improvements. A larger second trial is underway, one its researchers hope will lead to long-term treatment for children with autism.
Skeptics say there are too many unanswered questions to get excited. Even Duke researchers acknowledge as much. The initial trial, published Wednesday in the journal Stem Cells Translational Medicine, was a safety study, not a controlled, double-blind study with definitive proof of positive results. This study was open-label, meaning everyone — the doctors and the families — knew that the therapy was being administered.
But for the Gregorys, the change in their daughter has been monumental.
Our boy Wes, once looked into our eyes and giggled, interacted with us, crawled to us, mimicked our sounds and even had some starter words. Almost overnight he became a shell of himself after our doctor vaccinated him with DTAP, Tetanus Booster, Polio, Prevnar, and Hib, all in one day at 1/yr 8mths old to “catch him up”..
He became withdrawn, developed baggy dark eyes, allergies, he’d drag his head across the floor, developed aversions to clothing, sound and light sensitivities, teeth grinding, rocking, vocal swimming, stopped responding to his name even if it was shouted close by.
He lost that sparkle in his eye, the spark that once showed us he was alive. We started searching for answers and options for Wes and found Stem Cell Therapy and GcMaf.
Ageing, Rejuvenation Case Studies
Would you like to prevent the ageing process for a while and help your body to repair itself quicker and more like it used to? Well that’s essentially what having a large does of Cord Blood stem cells will do. Its an injection of youth, targeted to the very cells that are the most damaged and so need that change the most.
Cord Blood Stem cells are native, intelligent cells that have the ability to divide indefinitely. They can functionally change into any cell in our body and can integrate to target tissue, either in the presence or absence of damage. Stem cells are “undifferentiated” cells, which allow them to develop into another type of cell that is required to repair or replace damaged tissue.
Stem cell therapy can repair tissues that are too damaged to heal on their own.
